Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Korro Bio
Biotech
Novo Nordisk signs $530M biobucks deal to sing in Korro's opera
Novo isn’t done with the RNA deals, this time penning a $530 million biobucks deal to work with Korro on two cardiometabolic-related targets.
James Waldron
Sep 16, 2024 9:40am
Korro Bio merges with off-pitch Frequency, tacks on $117M
Jul 14, 2023 9:50am
Billy Dunn departs FDA—Chutes & Ladders
Mar 3, 2023 9:30am
Korro Bio rings in new year with $116M for OPERA RNA editing
Jan 5, 2022 7:30am
Proxy brawler Denner joins board at Ironwood—Chutes & Ladders
Nov 13, 2020 10:20am
Bermingham's Korro Bio lands ex-Corvidia executive as CEO
Nov 11, 2020 7:26am
